World Athletics has introduced a controversial new regulation requiring all female athletes to undergo a one-time SRY gene test before participating in the upcoming World Championships in Tokyo. The policy, set to take effect on September 1, 2025, mandates that all competitors in the women’s category be tested to verify their biological sex. This move is being implemented to, according to leadership, protect the integrity of women’s sports and ensure fair competition.
The SRY gene, which plays a critical role in male sex determination, will be tested using a cheek swab or blood sample, depending on the athlete’s preference. The responsibility for administering the test lies with individual Member Federations, who will handle the logistics and ensure compliance as part of preparations for the Tokyo event, scheduled to begin on September 13.
World Athletics President Seb Coe has strongly defended the decision, emphasizing that the organization’s priority is to maintain the credibility and fairness of female competitions. According to Coe, the regulation is essential in preserving an environment where women feel assured that they are competing on a level playing field. He stated that allowing unregulated participation could risk creating a “biological glass ceiling” for female athletes, potentially undermining confidence in the sport.
Despite the federation’s justification, the decision has drawn widespread criticism from the public and advocacy groups. Many have voiced concerns over the ethical and human rights implications of such testing. Social media platforms have seen an outpouring of negative responses, with critics calling the policy discriminatory, invasive, and potentially targeting women from specific racial or gender identity backgrounds.
The controversy raises deeper questions about inclusion, privacy, and the definition of fairness in sport. While World Athletics aims to uphold what it sees as scientific and competitive integrity, others argue that the approach may alienate and marginalize athletes who do not fit traditional biological definitions.
As the championship approaches, the debate over the SRY gene test is likely to intensify, with ongoing discussions around how sports bodies balance fairness, inclusivity, and scientific standards in elite competition.
